AnaptysBio: Funding, Investors & Team (Sep 2026)
AnaptysBio is a privately-owned company that specializes in therapeutic antibody products. They utilize somatic hypermutation (SHM) for discovering and enhancing antibodies, which is the body's natural way of creating strong antibodies to combat diseases. The company's SHM-Platform incorporates SHM and other methods to develop antibodies for therapeutic purposes through a process of natural evolution and high-throughput selection, known as naturalizing antibodies. This platform can be used to discover and enhance antibodies for specific disease targets, as well as improve existing antibodies' binding capabilities. It offers a more effective approach to antibody discovery and protein optimization, addressing a gap in the therapeutic antibody industry caused by acquisitions and licensing agreements that have limited access to technologies.
AnaptysBio has raised $100M across 1 funding round on record, the most recent an undisclosed round of $100M announced in Aug 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AnaptysBio Company Profile and Key Stats
Latest funding round on record: Aug 2024.
AnaptysBio Funding Rounds
AnaptysBio Founders and Leadership Team
No contact details are on record for this team yet.
AnaptysBio Funding Compared to Other Biotechnology Startups
AnaptysBio's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AnaptysBio in Biotechnology and San Diego
Companies Similar to AnaptysBio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
AnaptysBio Funding FAQs
What does AnaptysBio do?
AnaptysBio is a privately-owned company that specializes in therapeutic antibody products. They utilize somatic hypermutation (SHM) for discovering and enhancing antibodies, which is the body's natural way of creating strong antibodies to combat diseases. The company's SHM-Platform incorporates SHM and other methods to develop antibodies for therapeutic purposes through a process of natural evolution and high-throughput selection, known as naturalizing antibodies. This platform can be used to discover and enhance antibodies for specific disease targets, as well as improve existing antibodies' binding capabilities. It offers a more effective approach to antibody discovery and protein optimization, addressing a gap in the therapeutic antibody industry caused by acquisitions and licensing agreements that have limited access to technologies.
How much funding has AnaptysBio raised?
AnaptysBio has raised $100M across 1 round on record. The most recent is an undisclosed round of $100M announced in Aug 2024.
When did AnaptysBio last raise funding?
AnaptysBio's most recent funding round on record is an undisclosed round of $100M, announced in Aug 2024.
Who founded AnaptysBio?
FundedIQ lists Andrew B. Cubitt (Founder) at AnaptysBio.
Where is AnaptysBio headquartered?
AnaptysBio is based in San Diego, California, United States.
How many employees does AnaptysBio have?
AnaptysBio is in the 101-250 employee band.
How does AnaptysBio's funding compare to other Biotechnology startups?
AnaptysBio's latest round of $100M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's AnaptysBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AnaptysBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.